Laddar...
Optimizing outcomes for patients with newly diagnosed multiple myeloma eligible for transplantation
High-dose therapy with autologous stem cell transplantation (HDT–ASCT) has been considered to be the standard frontline treatment for younger, fit patients with multiple myeloma (MM) since the 1990s. Efforts continue to optimize the use of HDT–ASCT with the aim of improving outcomes. One strategy ha...
Sparad:
| I publikationen: | Leukemia Suppl |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4851188/ https://ncbi.nlm.nih.gov/pubmed/27175256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leusup.2013.4 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|